{"id":2219,"date":"2026-06-09T21:00:00","date_gmt":"2026-06-10T00:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2219"},"modified":"2026-06-09T21:00:00","modified_gmt":"2026-06-10T00:00:00","slug":"rss-clinica-medicina-cardiologia-clinica-hf-ef-arni-sgkt2i-insuficiencia-cardiaca-arritmia","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/rss-clinica-medicina-cardiologia-clinica-hf-ef-arni-sgkt2i-insuficiencia-cardiaca-arritmia\/","title":{"rendered":"RSS cardio cl\u00ednica: HF, ARNI, SGLT2i, IC"},"content":{"rendered":"

A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente subaproveitada por gestores de cl\u00ednicas de cardiologia cl\u00ednica que reduzem RSS a descarte de seringa e gaze<\/strong>. Em 2026, h\u00e1 um cen\u00e1rio desafiador \u2014 cl\u00ednicas de cardiologia cl\u00ednica<\/strong> + HF heart failure EF<40 HFrEF + EF 41-49 HFmrEF + EF\u226550 HFpEF<\/strong> + ARNI sacubitril\/valsartan Entresto Novartis pillar GDMT<\/strong> + SGLT2i empagliflozin Jardiance + dapagliflozin Forxiga + canagliflozin Invokana<\/strong> + ICD\/CRT-D Medtronic + Boston Sci + Abbott<\/strong> + arritmia Holter+Apple Watch+abla\u00e7\u00e3o radiofreq+crio<\/strong> + DOAC apixaban+rivaroxaban+dabigatran+edoxaban<\/strong> geram fluxos heterog\u00eaneos de RSS Grupo A1 (sangue venoso BNP+NT-proBNP+troponina+D-d\u00edmero) + Grupo A2 (eletrodo ECG 12-deriva\u00e7\u00f5es + Holter 24-72h + monitoriza\u00e7\u00e3o hemodin\u00e2mica) + Grupo B (ARNI Entresto + SGLT2i Jardiance\/Forxiga\/Invokana + DOAC Eliquis\/Xarelto\/Pradaxa\/Lixiana + carvedilol+bisoprolol+metoprolol BB + espironolactona+eplerenona MRA + finerenona Kerendia + tirzepatide Mounjaro Lista B\/C5) + Grupo E (perfuro Vacutainer + cateter venoso central CVC + introducer abla\u00e7\u00e3o + agulha pen). A consequ\u00eancia \u00e9 a pr\u00e1tica de cl\u00ednicas que otimizam apenas para sangue venoso<\/strong> + ignoram especificidades cardiol\u00f3gicas + ARNI + SGLT2i pillar<\/strong> + subdimensionam GDMT 4-pillar regimen<\/strong> + perdem rastreabilidade BNP+troponina<\/strong>. A realidade \u00e9 exatamente o oposto. RSS cardio cl\u00ednica opera em 5 fluxos cardiol\u00f3gicos<\/strong> \u2014 HF heart failure (HFrEF + HFmrEF + HFpEF + GDMT 4-pillar ARNI+BB+MRA+SGLT2i + finerenona Kerendia adicional), arritmia (FA AFib + FV + TV + bradi + Holter 24-72h + Apple Watch FA detection + abla\u00e7\u00e3o radiofreq Medtronic Arctic Front Crio + Abbott TactiCath), IC isqu\u00eamica (CAD coronary artery disease + IAM infarto Killip + STEMI\/NSTEMI + tirofiban Aggrastat + GP IIb\/IIIa), valvular (estenose a\u00f3rtica AS + insufici\u00eancia mitral MR + TAVI + MitraClip), DOAC anticoagula\u00e7\u00e3o (apixaban Eliquis + rivaroxaban Xarelto + dabigatran Pradaxa + edoxaban Lixiana + warfarina Marevan).<\/p>\n

Para o gestor que opera ou planeja cl\u00ednica de cardiologia cl\u00ednica, \u00e9 fundamental dimensionar RSS espec\u00edfico desde o in\u00edcio.<\/p>\n

Os 5 fluxos cardiol\u00f3gicos<\/h2>\n

Em uma opera\u00e7\u00e3o de qualquer porte, o RSS cardio cl\u00ednica tem 5 fluxos.<\/p>\n\n\n\n\n\n\n\n\n\n
Fluxo<\/th>\nVolume<\/th>\nFrequ\u00eancia<\/th>\nParticularidade<\/th>\n<\/tr>\n<\/thead>\n
HF GDMT 4-pillar<\/td>\n4-12 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nARNI+BB+MRA+SGLT2i<\/td>\n<\/tr>\n
Arritmia FA+abla\u00e7\u00e3o<\/td>\n3-9 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nHolter+Apple Watch+abl<\/td>\n<\/tr>\n
IC isqu\u00eamica CAD<\/td>\n3-8 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nSTEMI\/NSTEMI+CAD<\/td>\n<\/tr>\n
Valvular TAVI\/Mitra<\/td>\n1,5-4 kg\/dia<\/td>\nP\u00f3s-procedimento<\/td>\nTAVI+MitraClip<\/td>\n<\/tr>\n
DOAC anticoag<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nEliquis+Xarelto+Pradaxa<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A soma t\u00edpica \u00e9 13,5-39 kg\/dia<\/strong> em cl\u00ednica cardio cl\u00ednica m\u00e9dia porte.<\/p>\n

HF GDMT 4-pillar ARNI+BB+MRA+SGLT2i + finerenona: o est\u00e1gio insufici\u00eancia card\u00edaca<\/h2>\n

A primeira camada \u00e9 HF. Padr\u00e3o setorial inclui (a) HFrEF EF<40%<\/strong> com GDMT 4-pillar regimen + (1) ARNI sacubitril\/valsartan Entresto 24\/26-49\/51-97\/103 mg BID Novartis PARADIGM-HF + (2) BB beta-blocker carvedilol Coreg+bisoprolol Concor+metoprolol Toprol XL + (3) MRA mineralocorticoid receptor antagonist espironolactona Aldactone+eplerenona Inspra + (4) SGLT2i empagliflozin Jardiance+dapagliflozin Forxiga DAPA-HF + EMPEROR-Reduced; (b) HFpEF EF\u226550%<\/strong> com SGLT2i empagliflozin EMPEROR-Preserved + dapagliflozin DELIVER + spironolactona TOPCAT-Russia\/Georgia subgroup + finerenona Kerendia FINEARTS-HF; (c) HFmrEF EF 41-49%<\/strong> com GDMT regimen similar HFrEF + classe IIa recomenda\u00e7\u00e3o; (d) device<\/strong> com ICD implantable cardioverter defibrillator Medtronic Evera+Boston Sci Inogen+Abbott Ellipse + CRT-D cardiac resynchronization Medtronic Cobalt+Boston Sci Resonate+Abbott Quadra Allure MP biventricular pacing; (e) biomarker<\/strong> BNP brain natriuretic peptide >35 pg\/mL + NT-proBNP N-terminal proBNP >125 pg\/mL + troponina-T+I + ST2 + galectina-3 + biomarker congestion BIB-CHF.<\/p>\n

Cl\u00ednica com HF GDMT madura escala redu\u00e7\u00e3o mortalidade 35-50%<\/strong> + previne reinterna\u00e7\u00e3o<\/strong> + otimiza titula\u00e7\u00e3o dose m\u00e1xima<\/strong>. Como discutimos no post sobre hospital especializado<\/a>, HF GDMT \u00e9 base.<\/p>\n

Arritmia FA+TV+abla\u00e7\u00e3o radiofreq+crio + ICD\/CRT-D + DOAC: o est\u00e1gio el\u00e9trico<\/h2>\n

A segunda camada \u00e9 arritmia+device+anticoag. Padr\u00e3o setorial inclui (a) FA atrial fibrillation<\/strong> com parox\u00edstica+persistente+permanente + AHA\/ESC\/SBC + CHA2DS2-VASc score risco AVC + HAS-BLED score risco hemorragia + EHRA classe sintoma; (b) DOAC Direct Oral Anticoagulant<\/strong> com apixaban Eliquis 5mg BID + rivaroxaban Xarelto 20mg QD + dabigatran Pradaxa 150mg BID + edoxaban Lixiana 60mg QD + warfarina Marevan\/Coumadin INR 2-3 + revers\u00e3o idarucizumab Praxbind+andexanet alfa Andexxa; (c) abla\u00e7\u00e3o radiofreq<\/strong> com Medtronic Arctic Front Cryoballoon + Abbott TactiCath Sensor Enabled radiofreq + Biosense Webster CARTO + Boston Sci Rhythmia + EnSite Precision; (d) TV\/FV ventricular<\/strong> com ICD profil\u00e1tica prim\u00e1ria+secund\u00e1ria + Medtronic Evera+Sphera + Boston Sci Inogen+Resonate + Abbott Ellipse+Gallant + S-ICD subcut\u00e2neo Boston Sci Emblem; (e) monitor<\/strong> Holter 24-72h + Apple Watch Series 9 ECG FA detection FDA-cleared + AliveCor KardiaMobile + Zio Patch iRhythm + LINQ ICM Medtronic implantable cardiac monitor 3 anos.<\/p>\n

Cl\u00ednica com arritmia+device+DOAC madura escala FA detection precoce<\/strong> + previne AVC isqu\u00eamico cardioemb\u00f3lico<\/strong> + escala abla\u00e7\u00e3o success rate 70-85%<\/strong>. Conex\u00e3o com cardio adulto<\/a>.<\/p>\n

IC isqu\u00eamica STEMI\/NSTEMI + valvular TAVI + MitraClip + tirzepatide: o est\u00e1gio interven\u00e7\u00e3o+metab\u00f3lico<\/h2>\n

A terceira camada \u00e9 isqu\u00eamica+valvular+metab\u00f3lico. Padr\u00e3o setorial inclui (a) STEMI ST-Elevation Myocardial Infarction<\/strong> com PCI prim\u00e1ria <90min door-to-balloon + ticagrelor Brilinta+prasugrel Effient+clopidogrel Plavix DAPT 12m + estatina alta intensidade Lipitor+Crestor+Livalo + LDL-C target <55 mg\/dL HR; (b) NSTEMI Non-ST-Elevation MI<\/strong> com troponina-T+I + GRACE score + TIMI score + PCI eletiva + CABG + DAPT 12m + estatina; (c) valvular AS estenose a\u00f3rtica<\/strong> com TAVI Edwards SAPIEN 3 Ultra + Medtronic CoreValve Evolut + Boston Acurate Neo R$ 80-180k transcateter + AVR cir\u00fargica pacientes baixo risco; (d) MR insufici\u00eancia mitral<\/strong> com MitraClip Abbott + Pascal Edwards + Cardioband + Tendyne TMVR + EVOQUE Edwards + Watchman LAA Boston Scientific R$ 25-45k oclus\u00e3o ap\u00eandice atrial; (e) metabolic incretin<\/strong> com tirzepatide Mounjaro Eli Lilly GLP-1+GIP dual + semaglutida Ozempic Novo Nordisk GLP-1 + cagrilintide+semaglutide CagriSema + retatrutide GIP+GLP-1+glucagon triple Eli Lilly fase 3 + reduzir CV risk SUMMIT.<\/p>\n

Cl\u00ednica com isqu\u00eamica+valvular+metab\u00f3lico madura escala door-to-balloon <90min<\/strong> + escala TAVI sobrevida 5-7y<\/strong> + escala redu\u00e7\u00e3o CV risk -20-30%<\/strong>. Conex\u00e3o com Lista C5<\/a>.<\/p>\n

Tr\u00eas perfis de RSS por capacidade cardio cl\u00ednica<\/h2>\n

Cl\u00ednica cardio b\u00e1sica.<\/strong> 2 fluxos. Custo mensal R$ 12.000-32.000<\/strong> mas perda de ARNI+SGLT2i+abla\u00e7\u00e3o+TAVI.<\/p>\n

Cl\u00ednica cardio m\u00e9dia.<\/strong> 3 fluxos. Custo mensal R$ 24.000-58.000<\/strong>, captura HF+arritmia+IC.<\/p>\n

Cl\u00ednica cardio completa 5 fluxos.<\/strong> HF+arritmia+IC+valvular+DOAC + integra\u00e7\u00e3o com servi\u00e7os hospitalares<\/a>. Custo mensal R$ 45.000-105.000<\/strong>, efic\u00e1cia 95%, ROI 800-2.500% via captura cardiol\u00f3gica + GDMT mortality reduction + TAVI sobrevida.<\/p>\n

Os tr\u00eas erros que aparecem em cardio cl\u00ednica<\/h2>\n

O primeiro \u00e9 a subdimensionamento GDMT 4-pillar<\/strong>. Sem ARNI+BB+MRA+SGLT2i + finerenona = subaproveitamento Class I A + perda redu\u00e7\u00e3o mortalidade 35-50% + risco reinterna\u00e7\u00e3o 30%.<\/p>\n

O segundo \u00e9 a mistura DOAC + warfarina<\/strong>. Confunde rastreabilidade INR vs DOAC + impossibilita revers\u00e3o idarucizumab\/andexanet espec\u00edfica + risco hemorragia.<\/p>\n

O terceiro \u00e9 a falta de protocolo door-to-balloon STEMI<\/strong>. Sem PCI prim\u00e1ria <90min + ticagrelor\/prasugrel + estatina alta intensidade = perda salvamento mioc\u00e1rdio + risco mortalidade 30d.<\/p>\n

A regula\u00e7\u00e3o de RSS cardio cl\u00ednica no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com cardiologia especializada como prioridade. As institui\u00e7\u00f5es que estruturam fluxos completos desde o in\u00edcio \u2014 alinhadas com calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A SBC Sociedade Brasileira Cardiologia<\/a> \u00e9 refer\u00eancia t\u00e9cnica nacional.<\/p>\n

Solicite cota\u00e7\u00e3o RSS cardio cl\u00ednica 5 fluxos completos<\/a><\/strong> \u2014 cap\u00edtulo dedicado a HF GDMT 4-pillar ARNI Entresto Novartis PARADIGM-HF+BB carvedilol+bisoprolol+metoprolol+MRA espironolactona+eplerenona+SGLT2i empagliflozin Jardiance EMPEROR-Reduced+dapagliflozin Forxiga DAPA-HF+DELIVER+finerenona Kerendia FINEARTS-HF+BNP\/NT-proBNP+ICD\/CRT-D Medtronic+Boston Sci+Abbott, arritmia FA CHA2DS2-VASc+HAS-BLED+abla\u00e7\u00e3o Medtronic Arctic Front Cryo+Abbott TactiCath+Biosense CARTO+Boston Rhythmia+Apple Watch+AliveCor+Zio iRhythm+LINQ ICM, IC STEMI\/NSTEMI door-to-balloon<90min+ticagrelor Brilinta+prasugrel Effient+clopidogrel+estatina alta intensidade LDL<55+TIMI+GRACE, valvular TAVI Edwards SAPIEN 3 Ultra+Medtronic CoreValve Evolut+Boston Acurate Neo+MitraClip Abbott+Pascal Edwards+Watchman LAA, DOAC apixaban Eliquis+rivaroxaban Xarelto+dabigatran Pradaxa+edoxaban Lixiana+idarucizumab Praxbind+andexanet Andexxa+tirzepatide Mounjaro+semaglutida Ozempic Lista B\/C5.<\/p>\n","protected":false},"excerpt":{"rendered":"

RSS cardio: HF + ARNI + SGLT2i + IC + arritmia + DOAC. Veja.<\/p>\n","protected":false},"author":3,"featured_media":2218,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[3053,1911,3052,3054],"class_list":["post-2219","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-arni","tag-cardiologia","tag-hf","tag-sglt2i"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2219"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2219\/revisions"}],"predecessor-version":[{"id":4333,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2219\/revisions\/4333"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2218"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}